The positive correlation of Gli3 with tumor progression has been observed in HCC (62), pancreatic cancer (63), colon cancer (64), ovarian cancer (65), breast cancer (65), and bladder cancer (66). The gene discussed is GLI3; the disease is pancreatic neoplasm.